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Introduction
Sacrococcygeal teratoma (SCT) is a rare subset of germ
cell neoplasms, but is the most common congenital
tumor of the newborn, with an incidence of one in
35,000–40,000 live births. SCT is more common in
female than male children, and may occur in twin
pregnancies [1,2]. Antenatal diagnosis of SCT can be
made by ultrasound during the second trimester or
even earlier in the first trimester [3,4]. SCT parasitizes
blood supply from the internal and external iliac systems
and results in vascular shunting to the rapidly grow-
ing tumor. Large tumors during early gestation cause
significant prenatal mortality due to placentomegaly,
fetal hydrops or high-output cardiac failure [2,3]. Most
SCTs are benign, but about 20% are malignant, though
this is rare in the neonatal period (i.e. < 1 month old)
[2]. Complete surgical excision of the tumor is the
appropriate primary therapy in patients with SCT and
should avoid damage to pelvic-associated structures
[2]. We describe a dizygotic twin who was diagnosed
with fetal SCT by prenatal ultrasound examination, and
who underwent postnatal surgical removal of the tumor
after planned cesarean section.
Case Report
A 21 year-old, gravida 2, para 0, abortus 1, woman was
diagnosed with a fetal SCT in a dizygotic twin pregnancy
at 30 weeks of gestation by ultrasound examination.
SUMMARY
Objective: Sacrococcygeal teratoma (SCT) is the most common congenital tumor of the newborn. About 20%
of SCTs are malignant. We report the case of a dizygotic twin with a large immature SCT who was successfully
delivered by cesarean section at 34 weeks’ gestation and who underwent surgical removal of the tumor.
Case Report: A 21-year-old, gravida 2, para 0, abortus 1, woman was referred to Chung Shan Medical University
(CSMU) Hospital at 33 weeks’ gestation because of the diagnosis of a twin pregnancy with SCT in one twin.
There were no remarkable findings by ultrasound examination during the second trimester. At 30 weeks of
gestation, a sacral mass measuring 8.4 cm in diameter and with multi-cystic and solid components attached
to the coccyx was identified sonographically. The patient was referred to CSMU Hospital and underwent planned
cesarean section at 34 weeks of gestation. The sick twin was delivered smoothly and underwent surgical resection
of the tumor at 1 week of age after magnetic resonance imaging studies. Immature SCT with free surgical
margins was confirmed by pathologic examination. The infant did well postoperatively.
Conclusion: SCT diagnosed before birth can be managed by planned abdominal delivery and postnatal surgery.
Patients with immature teratomas should be followed-up long-term for recurrence and distant metastases.
[Taiwanese J Obstet Gynecol 2005;44(2):196–199]
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There were no remarkable findings during regular
prenatal care. At 16 weeks of gestation, maternal _-
fetoprotein (AFP) was 226.83 ng/mL and human
chorionic gonadotropin (hCG) was 106,482.77 mIU/
mL (Down syndrome risk, 1/1,739; neural tube defect
risk, 1/305). At 30 weeks of gestation, a sacral cystic
mass measuring 8.4 cm in diameter and with solid
components was identified incidentally by ultrasound
in the local obstetric clinic.
The patient was referred to the obstetrics and
gynecology clinic of Chung Shan Medical University Hos-
pital for further evaluation at 33+2 weeks’ gestation
due to rapid growth of the tumor. A large SCT (11.9 =
9.5 cm) in one twin fetus was diagnosed by abdominal
ultrasound at the time of the clinic visit (Figure 1A).
After detailed ultrasound examination, vascularization
in the central solid component was identified, but there
was no appreciable vascular shunting within the tumor
(resistance index, 1.47; pulsatility index, 2.65) (Figure
1B). Neither cardiomegaly nor genitourologic anomalies
were found under ultrasound examination.
At 34+5 weeks of gestation, the estimated body
weight of each twin was greater than 2,000 g, and
planned cesarean section was performed. Twin A
(female; birth weight, 2,500 g; Apgar scores, 7 and 9 at
1 and 5 minutes) and twin B with a large sacral mass
(female; birth weight, 2,694 g; Apgar scores, 7 and 9 at
1 and 5 minutes) were delivered smoothly (Figure 2A).
Twin A was normal in appearance without congenital
anomalies. Twin B presented with an external sacral
mass 15 cm in diameter, and the anus was displaced
anteriorly (Figure 2B); otherwise, no additional con-
genital anomalies were identified.
Tumor markers of the delivered twins demonstrated
markedly high serum AFP (twin A, 50,028.1 ng/mL;
twin B with sacral tumor, 41,054.5 ng/mL). Magnetic
resonance imaging (MRI) revealed a large external
mass with multi-cystic and solid components, and no
pelvic or intra-abdominal mass in twin B (Figure 1C).
The neonatal SCT was categorized as Altman’s type I
according to the location of the tumor [2].
After consultation with the pediatric surgeon, twin B
underwent complete surgical removal of the tumor at 1
week of age. Immature solid teratoma composed of
immature embryonal-type tissue mixed with mature
tissues was confirmed by pathologic examination. The
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Figure 1. (A) Prenatal ultrasonography at 33+2 weeks’ gesta-
tion revealed a cystic complex with solid components and
calcification, measuring 11.9 = 9.5 cm. (B) Detailed ultrasound
examination of the vascularization of the solid component
showed minimal vascular shunting within the tumor (resistance
index, 1.47; pulsatility index, 2.65. (C) Postnatal magnetic
resonance imaging revealed an external sacral complex with
multi-cystic and solid components, with no pelvic or intra-
abdominal lesions (c = cyst; s = solid component; sc = sacro-
coccygeum).
Figure 2. Dizygotic twins were delivered by cesarean section at
34 weeks of gestation: (A) twin A was normal in appearance
with no congenital anomalies, and twin B presented with a
large sacrococcygeal mass without additional congenital
anomalies; (B) the tumor measured 15 = 10 = 9.5 cm and the
anus was displaced anteriorly (arrow).
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surgical margin was free of tumor and biopsy of coccygeal
bone was negative for malignancy. Surgical removal
of the tumor was complete and twin B did well post-
operatively. Both twins were closely followed-up.
Discussion
The exact etiology of SCT is unknown [2]. Ronald et al
first described SCT diagnosed by prenatal ultrasono-
graphy in a male twin in 1985 [5]. The lesion was not of
sufficient size for detection during the second trimester,
but was clearly visualized at 30 weeks of gestation. The
sick twin underwent complete resection of the tumor
and pathologic examination revealed three germ cell
layers with abundant immature neuroectodermal tissue.
Postoperatively, the male infant progressed well [5].
The female twin B presented in this study is similar to
that reported by Ronald et al [5].
Malignancy of SCT is very rare in the neonate (< 1
month of age). Surgery and chemotherapy are the sug-
gested treatments [2,6–8]. Altman et al found that
when the tumor is discovered before the age of 1 month,
the risk of malignancy is only about 5% [2]. Between 1
and 12 months of age, the malignancy rate is about
60%. In most patients, surgery is the principal therapy
for SCT and should be performed in toto within the first
week after delivery. The long-term survival rate of
neonates after surgery for benign tumors is 92–95%, and
that of malignant tumors is about 20% [6,9]. About
23% of immature teratomas recur after surgical resection
(as determined by the detection of an elevated serum
AFP). Multi-agent chemotherapy may be beneficial
for treatment of tumor recurrence [6,7]. Hedrick et al
described a patient with mixed mature/immature SCT
and subsequent sacral recurrence who had an excellent
response after treatment with four cycles of etoposide,
carboplatin and bleomycin [8]. Serum AFP levels,
computed tomography (CT) or MRI may be helpful in
detecting occult recurrences or metastases of malignant
tumors [7,8].
Altman et al defined four types of SCT according
to the location of the tumor [2]. Our patient had an
Altman type I tumor, i.e. predominantly external on
the buttocks with a minimal presacral component.
Altman type I tumors account for most SCTs (47%). In
large clinical series, more than 90% of type I SCTs are
successfully removed at the initial operation. All SCTs
should be regarded as having malignant potential. About
5% of patients with SCT have metastatic disease at the
time of diagnosis [2,6].
Large SCTs cause prenatal death due to high-output
cardiac failure resulting from vascular shunting; they
need immediate intervention before childbirth. Prenatal
intervention in selected fetuses with SCT includes open
fetal surgery or radiofrequency ablation in utero to pre-
vent fetal death secondary to vascular steal in a rapidly
growing solid tumor [8,10]. Chen and Shih reported
that three-dimensional color power angiography allows
the visualization of blood flow between the SCT and
fetal circulation, and facilitates the targeted ablation
of the feeding tumor vessels to interrupt blood flow
[11]. Hedrick et al reported that surgical debulking of
the tumor in utero has proven successful in carefully
selected patients based on ultrasonographic and echo-
cardiographic evidence of impending heart failure and
favorable anatomy [8]. Large SCT did not cause a
problem for this twin B fetus. This may have been
because the tumor was mainly composed of cystic tissue
and had no profuse vascularity within it. Vascular steal
was not a cause of significant effects in high cardiac
output.
AFP levels in our delivered twins were markedly
elevated and demanded close follow-up as AFP is an
indicator for malignancy. In newborns, the use of AFP in
this manner is somewhat complicated because AFP is
normally high in neonates [12]. Wu et al reported a
mean AFP level in healthy newborns of 48,000 ng/mL,
and that AFP in neonates 8 months of age had returned
to the normal value of 8.5 ng/mL [12].
In this twin B with SCT, adequate follow-up of serial
AFP levels will be performed at the age of 8 months after
delivery. The normal twin will also be closely followed-
up until AFP returns to normal. Elevated AFP levels
indicate recurrence or metastases, so twin B with SCT
will receive complete investigative oncologic studies.
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